Good Financial Grant Practice (GFGP): A Tool for Developing & Demonstrating Institutional Financial & Grant Management Capacity in Global Health

Vista sencilla de ítem
dc.audienceInvestigador
dc.creatorHarste, Harry J.
dc.creatorGenevieve, Kiff
dc.creatorOkeke, Iruka N.
dc.creatorAdebiyi, Akindele O.
dc.creatorRavikumar, K. L.
dc.creatorNagaraj, Geetha
dc.creatorAjiboye, Jolaade J.
dc.creatorOsma Castro, Erik C. D.
dc.creatorHerrera, Elmer
dc.creatorAanensen, David M.
dc.date2024-07-31T14:02:35Z
dc.date2024-07-31T14:02:35Z
dc.date2021-06-28
dc.date2021
dc.date.accessioned2026-06-27T04:40:06Z
dc.descriptionThe administration and governance of grant funding across global health organizations presents enormous challenges. Meeting these challenges is crucial to ensuring that funds are used in the most effective way to improve health outcomes, in line with the United Nations' Sustainable Development Goal (SDG) 3, “Ensure healthy lives and promote well-being for all at all ages.” The Good Financial Grant Practice (GFGP) Standard (ARS 1651) is the world’s first – and currently only – international standard in the financial governance and management of grant funding. Through consensus building and global harmonization between both low and middle-income, and high-income country players, the GFGP Standard has achieved a levelling impact: GFGP applies equally to, and can be implemented by, all types of organization, regardless of location, size, or whether they predominantly give or receive funding. GFGP can be used as a tool for addressing some of the challenges of the current funding model. We describe our experiences and lessons learned from implementing GFGP across four diverse research institutions in India, Nigeria, Colombia, and the Philippines, as part of our UK National Institute for Health Research Global Health Research Unit (GHRU) on Genomic Surveillance of Antimicrobial Resistance.
dc.formatapplication/pdf
dc.formatapplication/pdf
dc.identifierhttps://osf.io/preprints/osf/6fwb5
dc.identifierhttp://hdl.handle.net/20.500.12324/39729
dc.identifierhttps://doi.org/10.31219/osf.io/6fwb5
dc.identifierreponame:Biblioteca Digital Agropecuaria de Colombia
dc.identifierinstname:Corporación colombiana de investigación agropecuaria AGROSAVIA
dc.identifier.urihttp://hdl.handle.net/123456789/34802
dc.languageeng
dc.publisherOfficial Development Assistance - ODA
dc.relationOSFPreprints
dc.relation16
dc.relation16
dc.relation1
dc.relation23
dc.relationSridhar D, Batniji R. Misfinancing global health: a case for transparency in disbursements and decision making. Lancet. 2008; 372(9644): 1185-1191. doi:10.1016/S0140-6736(08)61485-3
dc.relationKates J, Morrison JS, Lief E. Global health funding: a glass half full? Lancet. 2006; 368(9531): 187-188. doi:10.1016/S0140-6736(06)69018-1
dc.relationXu K, Soucat A, Kutzin J, et al. New Perspectives on Global Health Spending for Universal Health Coverage. Geneva: World Health Organization, 2018. Available at: https://apps.who.int/iris/bitstream/handle/10665/259632/WHO-HIS-HGF-HFWorkingPaper-17.10- eng.pdf. Accessed June 9, 2021.
dc.relationUnited Nations Department of Economic and Social Affairs. Sustainable Development Goal 3: Ensure healthy lives and promote well-being for all at all ages. Available at: https://sdgs.un.org/goals/goal3. Accessed June 9, 2021.
dc.relationCrane JT. Scrambling for Africa: AIDS, expertise, and the rise of American global health science. African Affairs, 2014; 114(454): 160-161. https://doi.org/10.1093/afraf/adu068
dc.relationCollignon P, Athukorala PC, Senanayake S, Khan F. Antimicrobial resistance: the major contribution of poor governance and corruption to this growing problem. PLoS One. 2015; 10(3): e0116746. Published 2015 Mar 18. doi:10.1371/journal.pone.0116746
dc.relationChu KM, Jayaraman S, Kyamanywa P, Ntakiyiruta G. Building research capacity in Africa: equity and global health collaborations. PLoS Med. 2014; 11(3): e1001612. Published 2014 Mar 11. doi:10.1371/journal.pmed.1001612
dc.relationBeran D, Byass P, Gbakima A, et al. Research capacity building-obligations for global health partners. Lancet Glob Health. 2017; 5(6): e567-e568. doi:10.1016/S2214-109X(17)30180-8
dc.relationBhutta Z. Practising just medicine in an unjust world. BMJ. 2003; 327(7422): 1000-1001. doi:10.1136/bmj.327.7422.1000
dc.relationFeagins AR, Vuong J, Fernandez K, et al. The Strengthening of Laboratory Systems in the Meningitis Belt to Improve Meningitis Surveillance, 2008-2018: A Partners' Perspective. J Infect Dis. 2019; 220(220 Suppl 4): S175-S181. doi:10.1093/infdis/jiz337
dc.relationEckhart-Queenan J, Etzel M, Prasad S. Pay-What-It-Takes Philanthropy. Stanford Social Innovation Review. 2016. Available at: https://ssir.org/up_for_debate/article/pay_what_it_takes_philanthropy#. Accessed June 9, 2021.
dc.relationGoggins Gregory A, Howard D. The Nonprofit Starvation Cycle. Stanford Social Innovation Review, 2009. Available at: https://ssir.org/articles/entry/the_nonprofit_starvation_cycle. Accessed June 9, 2021.
dc.relationEckhart Queenan J, Allen J, Tuomala J. Stop Starving Scale: Unlocking the Potential of Global NGOs: Bridgespan, 2013. Available at: https://www.bridgespan.org/insights/library/pay-what-ittakes/ unlocking-the-potential-of-global-ngos. Accessed June 9, 2021.
dc.relationAsian Development Bank. Financial Due Diligence: A Methodology Note. January 2009. Available at: https://www.adb.org/documents/financial-due-diligence-methodology-note. Accessed June 9, 2021.
dc.relationCrane JT, Andia Biraro I, Fouad TM, Boum Y 2nd, R Bangsberg D. The 'indirect costs' of underfunding foreign partners in global health research: A case study. Glob Public Health. 2018; 13(10): 1422-1429. doi:10.1080/17441692.2017.1372504
dc.relationNational Institute for Health Research. NIHR Global Health Research Units and Groups FAF Guidance. Available at: https://www.nihr.ac.uk/documents/nihr-global-health-research-units-andgroups- faf-guidance/22789. Accessed June 9, 2021.
dc.relationNational Institute for Health Research. Global Health Research Programmes - Core Guidance. Available at: https://www.nihr.ac.uk/documents/nihr-global-health-research-programmes-stage-2- applications-core-guidance/24952. Accessed June 9, 2021.
dc.relationGarcía PJ. Corruption in global health: the open secret. Lancet. 2019; 394(10214): 2119-2124. doi:10.1016/S0140-6736(19)32527-9
dc.relationMay O. Fighting Fraud and Corruption in the Humanitarian and Global Development Sector. Routledge, 2019; 3-5.
dc.relationEls C. Country-based pooled funds: The NGO perspective: Norwegian Refugee Council, 2019. Available at: https://www.nrc.no/resources/reports/country-based-pooled-funds-the-ngo-perspective/. Accessed June 9, 2021.
dc.relationARMA UK. First Output From The ‘Consolidated Approach To Assurance And Due Diligence’ Project. Available at: https://arma.ac.uk/first-output-from-the-consolidated-approach-to-assuranceand- due-diligence-project/. Accessed June 9, 2021.
dc.relationThe Global Grant Community. Good Financial Grant Practice. Available at: https://www.globalgrantcommunity.com/. Accessed June 9, 2021.
dc.relationYao K, Maruta T, Luman ET, Nkengasong JN. The SLMTA programme: Transforming the laboratory landscape in developing countries. Afr J Lab Med. 2014; 3(3): 194. doi:10.4102/ajlm.v3i2.194
dc.relationKekre M, Arevalo SA, Valencia MF, et al. Integrating Scalable Genome Sequencing into Microbiology Laboratories for Routine AMR Surveillance. Clin Infect Dis 2021;73: In this supplement
dc.relationAfolayan AO, Bernal JF, Gayeta JM, et al. Overcoming data bottlenecks in genomic pathogen surveillance. Clin Infect Dis 2021;73: In this supplement
dc.relationFolarin OA, Happi AN, Happi CT. Empowering African genomics for infectious disease control. Genome Biol. 2014; 15(11): 515. Published 2014 Nov 7. doi:10.1186/s13059-014-0515-y
dc.relationOkeke IN, Feasey N, Parkhill J, et al. Leapfrogging laboratories: the promise and pitfalls of hightech solutions for antimicrobial resistance surveillance in low-income settings. BMJ Global Health. 2020; 5: e003622
dc.relationTessema SK, Inzaule SC, Christoffels A, et al. Accelerating genomics-based surveillance for COVID-19 response in Africa. Lancet Microbe. 2020; 1(6): e227-e228. doi:10.1016/S2666- 5247(20)30117-8
dc.relationArgimón S, Masim MAL, Gayeta JM, et al. Integrating whole-genome sequencing within the National Antimicrobial Resistance Surveillance Program in the Philippines. Nat Commun. 2020; 11(1): 2719. Published 2020 Jun 1. doi:10.1038/s41467-020-16322-5
dc.relationHumentum. Available at: https://www.humentum.org/. Accessed June 9, 2021.
dc.relationBDO LLP. BDO United Kingdom. Available at: https://www.bdo.co.uk/en-gb/home. Accessed June 9, 2021.
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International
dc.sourceOSFPreprints; Vol 16, Núm 16 (2021): OSFPreprints (June);p. 1-23.
dc.subjectGFGP
dc.subjectGood Financial Grant Practice
dc.subjectResearch funding
dc.subjectGrant management
dc.subjectGovernance
dc.subjectEconomía y políticas de desarrollo - E14
dc.subjectFinanza
dc.subjectDesarrollo rural
dc.subjectSalud
dc.subjectSostenibilidad
dc.subjectTransversal
dc.subjecthttp://aims.fao.org/aos/agrovoc/c_2901
dc.subjecthttp://aims.fao.org/aos/agrovoc/c_6701
dc.subjecthttp://aims.fao.org/aos/agrovoc/c_3511
dc.subjecthttp://aims.fao.org/aos/agrovoc/c_33560
dc.thumbnailhttps://repository.agrosavia.co/bitstreams/2be5ee8d-d4d6-45ae-a8fa-aa339b7d83d3/download
dc.titleGood Financial Grant Practice (GFGP): A Tool for Developing & Demonstrating Institutional Financial & Grant Management Capacity in Global Health
dc.titleGood Financial Grant Practice (GFGP): A Tool for Developing & Demonstrating Institutional Financial & Grant Management Capacity in Global Health
dc.typeArtículo científico

Archivos

Colecciones

Científico